Penserra Capital Management LLC Arbutus Biopharma Corp Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$3.11 - $4.61 $7,044 - $10,441	-2,265 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.65 - $4.62 $185 - $323	70 Added 3.19%	2,265 $9,000
Q2 2021 Aug 12, 2021	BUY	$2.5 - $3.51 $637 - $895	255 Added 13.14%	2,195 $6,000
Q1 2021 May 13, 2021	SELL	$3.14 - $4.84 $31 - $48	-10 Reduced 0.51%	1,940 $6,000
Q4 2020 Feb 12, 2021	BUY	$2.76 - $4.97 $5,382 - $9,691	1,950 New	1,950 $6,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.